Cronos Group Inc. (CRON.TO)
CAD 2.53
(2.02%)
CAD 2.53
(2.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 96.7 Million USD | -28.26% |
| 2022 | 127.98 Million USD | -28.66% |
| 2021 | 179.38 Million USD | 16.85% |
| 2020 | 153.51 Million USD | 56.18% |
| 2019 | 98.29 Million CAD | 355.73% |
| 2018 | 21.56 Million CAD | 190.44% |
| 2017 | 7.42 Million CAD | 142.0% |
| 2016 | 3.06 Million CAD | 98.06% |
| 2015 | 1.54 Million CAD | -30.35% |
| 2014 | 2.22 Million CAD | 424.82% |
| 2013 | 423.86 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 21.31 Million USD | 18.96% |
| 2024 Q1 | 18.37 Million USD | -8.51% |
| 2023 Q1 | 24.37 Million USD | -16.03% |
| 2023 FY | 91.81 Million USD | -28.26% |
| 2023 Q4 | 20.08 Million USD | -17.43% |
| 2023 Q3 | 24.32 Million USD | 2.54% |
| 2023 Q2 | 23.71 Million USD | -2.7% |
| 2022 Q2 | 30.91 Million USD | -15.06% |
| 2022 FY | 127.98 Million USD | -28.66% |
| 2022 Q1 | 36.39 Million USD | -10.57% |
| 2022 Q4 | 29.03 Million USD | -8.24% |
| 2022 Q3 | 31.63 Million USD | 2.33% |
| 2021 Q4 | 40.69 Million USD | -24.29% |
| 2021 Q1 | 40.49 Million USD | -6.93% |
| 2021 FY | 179.38 Million USD | 16.85% |
| 2021 Q3 | 53.75 Million USD | 20.99% |
| 2021 Q2 | 44.43 Million USD | 9.72% |
| 2020 Q2 | 31.8 Million USD | -17.58% |
| 2020 Q1 | 38.58 Million USD | 1.1% |
| 2020 Q4 | 43.51 Million USD | 9.79% |
| 2020 Q3 | 39.63 Million USD | 24.62% |
| 2020 FY | 153.51 Million USD | 56.18% |
| 2019 Q3 | 26.28 Million CAD | 31.28% |
| 2019 FY | 98.29 Million CAD | 355.73% |
| 2019 Q4 | 38.16 Million CAD | 45.19% |
| 2019 Q2 | 20.02 Million CAD | 92.69% |
| 2019 Q1 | 10.39 Million CAD | 22.81% |
| 2018 Q1 | 3.17 Million CAD | 42.0% |
| 2018 Q4 | 8.46 Million CAD | 56.83% |
| 2018 FY | 21.56 Million CAD | 190.44% |
| 2018 Q3 | 5.39 Million CAD | 21.18% |
| 2018 Q2 | 4.45 Million CAD | 40.04% |
| 2017 Q3 | 1.64 Million CAD | -18.75% |
| 2017 FY | 7.42 Million CAD | 142.0% |
| 2017 Q4 | 2.23 Million CAD | 36.47% |
| 2017 Q2 | 2.01 Million CAD | 51.92% |
| 2017 Q1 | 1.32 Million CAD | -14.2% |
| 2016 Q1 | 335.63 Thousand CAD | -44.09% |
| 2016 FY | 3.06 Million CAD | 98.06% |
| 2016 Q4 | 1.54 Million CAD | 96.17% |
| 2016 Q3 | 789.68 Thousand CAD | 95.07% |
| 2016 Q2 | 404.81 Thousand CAD | 20.61% |
| 2015 Q2 | 337.14 Thousand CAD | -19.05% |
| 2015 FY | 1.54 Million CAD | -30.35% |
| 2015 Q4 | 600.28 Thousand CAD | 146.03% |
| 2015 Q3 | 243.98 Thousand CAD | -27.63% |
| 2015 Q1 | 416.49 Thousand CAD | 0.0% |
| 2014 FY | 2.22 Million CAD | 424.82% |
| 2014 Q3 | 76.68 Thousand CAD | 697.61% |
| 2014 Q2 | 9613.92 CAD | 0.0% |
| 2013 FY | 423.86 Thousand CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | 39.0% |
| Avicanna Inc. | 14.59 Million CAD | -562.767% |
| Avant Brands Inc. | 5.65 Million CAD | -1608.942% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | -227.415% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | -684.976% |
| Knight Therapeutics Inc. | 155.54 Million CAD | 37.825% |
| MediPharm Labs Corp. | 23.08 Million CAD | -318.962% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | 65.189% |
| Canopy Growth Corporation | 308.61 Million CAD | 68.663% |
| Willow Biosciences Inc. | 7.55 Million CAD | -1180.236% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | -140.08% |